Summary:
Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Qualified Participants Must:
Be between 18 and 75 years of age
Have a primary diagnosis of Major Depressive Disorder (without psychosis)
Have a failure of at least 1 prior adequate trial of standard antidepressant in the current major depressive episode
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.